
Sanjay Shripat Marathe
About Sanjay Shripat Marathe
Data last updated:
Sanjay Shripat Marathe is a Director at Potion Pharmaceuticals Private Limited (since 2015). The companies operate in Pharma. Potion Pharmaceuticals Private Limited reported revenue of ₹21.9 Lakh (FY 2025). Earlier, Sanjay Shripat Marathe was a Director at Flex Automation Solutions Private Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Feb 2015 | 2015 | ₹21.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Mar 2012 | 1987 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Shripat Marathe
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sunita Sanjay Marathe | 03553251 | Potion Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Shripat Marathe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Shripat Marathe
Sanjay Shripat Marathe currently holds 1 directorship: Potion Pharmaceuticals Private Limited (Director, since 03 Feb 2015, revenue ₹21.9 Lakh (FY 2025)).
Sanjay Shripat Marathe was first appointed on 12 Mar 2012 as Director at Flex Automation Solutions Private Limited. The most recent appointment on record is 03 Feb 2015 at Potion Pharmaceuticals Private Limited.
Sanjay Shripat Marathe held 1 earlier board appointment: Flex Automation Solutions Private Limited (Director, from 12 Mar 2012).
The current boards of Sanjay Shripat Marathe's companies include Sunita Sanjay Marathe (Potion Pharmaceuticals Private Limited).